| 摘要 |
A diagnostic method of monitoring anti-inflammatory and/or antioxidant actio ns of therapeutic agents comprises determining the level of at least one system ic marker indicative of inflammation or oxidation in a bodily sample taken from a subject at base line or following administration of the therapeutic agent. T he marker includes at least one of MPO activity, MPO mass, select MPO-generated oxidation products, and combinations thereof. The level of the systemic mark er is compared with a predetermined value to monitor the anti-inflammatory and/ or antioxidant actions of the therapeutic agent.
|
